I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety, antitumor activity and biomarkers of sugemalimab in..:
Gong, Jifang
;
Cao, Junning
;
Zhang, Qingyuan
...
Cancer Immunology, Immunotherapy. 71 (2022) 8 - p. 1897-1908 , 2022
Link:
https://doi.org/10.1007/s00262-021-03102-3
RT Journal T1
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s00262-021-03102-3&Exemplar=1&LAN=DE A1 Gong, Jifang A1 Cao, Junning A1 Zhang, Qingyuan A1 Xu, Nong A1 Zhao, Yanqiu A1 Xing, Baocai A1 Miao, Zhanhui A1 Wu, Yilong A1 Pan, Hongming A1 Gao, Quanli A1 Li, Xingya A1 Liu, Baorui A1 Li, Wei A1 Pei, Zhidong A1 Xia, Hongqiang A1 Qi, Qinzhou A1 Dai, Hangjun A1 Shi, Qingmei A1 Yang, Jianxin A1 Li, Jin A1 Shen, Lin PB Springer Science and Business Media LLC YR 2022 SN 0340-7004 SN 1432-0851 JF Cancer Immunology, Immunotherapy VO 71 IS 8 SP 1897 OP 1908 LK http://dx.doi.org/https://doi.org/10.1007/s00262-021-03102-3 DO https://doi.org/10.1007/s00262-021-03102-3 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)